CRTAM Protein (His tag)
-
- Antigène Voir toutes CRTAM Protéines
- CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette CRTAM protéine est marqué à la His tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human CRTAM protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 95 % as determined by SDS-PAGE and Coomassie blue staining
- niveau d'endotoxine
- < 0.1 EU per μg protein as determined by LAL test
- Top Product
- Discover our top product CRTAM Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Buffer
- Lyophilized from a 0.2 μM filtered solution of 20 mM Phosphate buffer, 150 mM NaCl, pH 7.2. Stable for at least 6 months from date of receipt under proper storage and handling conditions.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))
- Autre désignation
- Crtam (CRTAM Produits)
- Synonymes
- TAD Protein, cTADS Protein, MGC82176 Protein, CRTAM Protein, CD355 Protein, cytotoxic and regulatory T-cell molecule Protein, cytotoxic and regulatory T-cell molecule L homeolog Protein, cytotoxic and regulatory T cell molecule Protein, CRTAM Protein, crtam.L Protein, Crtam Protein
- Sujet
- The CRTAM gene is upregulated in CD4 (see MIM 186940)-positive and CD8 (see CD8A MIM 186910)-positive T cells and encodes a type I transmembrane protein with V and C1-like Ig domains (Yeh et al., 2008 [PubMed 18329370]).[supplied by OMIM, Feb 2009].
- Poids moléculaire
- 31.0 kDa
- NCBI Accession
- NP_062550
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
-